Stay updated on Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A new revision label, Revision: v3.6.4, was added and the previous label, Revision: v3.6.3, was removed, indicating an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T12:36:58.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Update to revision label on the page from v3.6.2 to v3.6.3, indicating a new page version. This update likely includes minor behind-the-scenes changes without altering the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:57.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-26T23:50:52.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Recruitment status now indicates no further participant recruitment; new help sections were added to assist users in reading, understanding, and joining studies, along with minor label formatting changes and a revision tag.
    Difference
    0.5%
    Check dated 2026-06-12T16:46:55.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.5, replacing v3.5.4. This represents a small internal update to the page's revision history and does not change the displayed study information.
    Difference
    0.1%
    Check dated 2026-06-05T15:39:35.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    The page now displays a new revision label (v3.5.4), replacing the previous v3.5.3. This update reflects a new page revision in the metadata and does not change the underlying study content.
    Difference
    0.1%
    Check dated 2026-05-15T05:55:15.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Ibrutinib and Pembrolizumab in CLL/MCL Clinical Trial page.